EMBARC – What is Bronchiectasis?

What is Bronchiectasis? Bronchiectasis is a common, progressive respiratory disease characterised by permanent dilatation of the bronchi and presenting with a clinical syndrome of cough, sputum production and recurrent respiratory infections. Once considered an “orphan” disease, there is growing evidence …

Read more

EMBARC – Patient Resource

  EMBARC (the European Multicentre Bronchiectasis Audit and Research Collaboration) was established in 2012 to encourage and improve how researchers across Europe work together to improve the healthcare of patients with bronchiectasis. The aims of the EMBARC group are to …

Read more

EMBARC – References

List of references for the Education Section Weycker D, Edelsberg J, Oster G, Tine G. Prevalence and economic burden of bronchiectasis. Clin Pulm Med 2005;12:205 – 209. O’Brien C, Guest PJ, Hill SL, Stockley RA. Physiological and radiological characterisation of …

Read more

EMBARC – Treatment of bronchiectasis

Management The aims of bronchiectasis management are to reduce symptoms, reduce exacerbation frequency, preserve lung function and improve health related quality of life.[12,33] Patient education is of great importance as many patients have a high treatment burden with physiotherapy regimes, …

Read more

EMBARC – Severity assessment

Defining severity of disease and prognosis In contrast with other respiratory diseases like COPD, pulmonary fibrosis and pneumonia, which have well established disease severity scores,.[69-71] assessment of disease severity is relatively new concept in bronchiectasis. A combination of clinical, radiological …

Read more

EMBARC – Latest Research

Metersky M, Chalmers J / F1000Res. 2019 Mar 15;8. pii: F1000 Faculty Rev-293. doi: 10.12688/f1000research.17295.1. eCollection 2019. Chalmers JD. / Chest. 2018 Dec;154(6):1272-1273. doi: 10.1016/j.chest.2018.08.1051. No abstract available. O’Donnell AE. / J Thorac Dis. 2018 Oct;10(Suppl 28):S3428-S3435. doi: 10.21037/jtd.2018.09.39. Review. Radovanovic …

Read more

EMBARC – Microbiology

Microbiology Using traditional culture techniques pathogenic microorganisms are isolated in 2/3 to ¾ of patients with bronchiectasis, although we now know from modern molecular techniques sequencing the 16s bacterial ribosomal RNA gene (16s rRNA) that a large and diverse bacterial …

Read more

EMBARC – Courses and Resources

EMBARC organises educational events, training courses and seminars to spread knowledge regarding non-CF bronchiectasis. Below you will find details of educational activities and educational resources provided by the European Respiratory Society specifically related to bronchiectasis as well as activities and …

Read more

EMBARC – Assessment and diagnosis

Quality of Life Bronchiectasis has a significant effect on health related quality of life; mean total scores for the St. Georges Respiratory Questionnaire (a widely used quality of life questionnaire for respiratory disorders) in bronchiectasis range from 36, 41.1, 44.4 …

Read more

Contact

EMBARC
Carl-Neuberg-Straße 1, 30625 Hannover, Germany
[email protected]

Opening hours

Mon - Fr 10:00 - 17:00
Sat - 10:00 - 15:00
Sun - 10:00 - 13:00

Produkt zum Warenkorb hinzugefügt.
0 Artikel - 0,00